{"name":"Oxiracetam","slug":"oxiracetam","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Isf-2522","Cgp 21690e","Oxiracetamum","Cgp-21690e","Gnf-pf-1005","N06bx07","4-Hydroxy-2-oxopyrrolidine-N-acetamide","Hydroxypiracetam","4-Hydroxy-2-oxo-1-pyrrolidineacetamide","Oxiracetam(Random Configuration)"],"brands":[],"scraped":true,"has_structure":true,"cid":4626,"classes":[{"name":"antipsychotic","href":"/class/antipsychotic"}],"families":[{"name":"racetam","href":"/substituted/racetam"}],"physical":[{"label":"Molecular mass","value":"158.16 g/mol","copyable":false},{"label":"Predicted LogP","value":"-2.2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>6</sub>H<sub>10</sub>N<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide","copyable":true},{"label":"SMILES","value":"C1C(CN(C1=O)CC(=O)N)O","copyable":true},{"label":"InChI","value":"InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10)","copyable":true},{"label":"InChIKey","value":"IHLAQQPQKRMGSS-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"62613-82-5","copyable":true},{"label":"UNII","value":"P7U817352G","copyable":true},{"label":"PubChem CID","value":"4626","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"30-90 Minutes","copyable":false},{"label":"Elimination half-life","value":"8 hours","copyable":false},{"label":"Excretion","value":"Renal","copyable":false},{"label":"Routes of administration","value":"Oral, IV<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Marquis","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Mecke","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Mandelin","reacts":false,"colors":[],"description":"clear"},{"reagent":"Simon's","reacts":false,"colors":[],"description":"no blue color change"},{"reagent":"Ehrlich","reacts":false,"colors":[],"description":"no color change"},{"reagent":"Hofmann","reacts":false,"colors":[],"description":"no color change"}],"atc":[{"code":"N","description":"Nervous system"},{"code":"N06","description":"Psychoanaleptics"},{"code":"N06B","description":"Psychostimulants, agents used for adhd and nootropics"},{"code":"N06BX","description":"Other psychostimulants and nootropics"},{"code":"N06BX07","description":"Oxiracetam"}],"mesh":[{"name":"Psychotropic Drugs","id":"M0018063"},{"name":"Nootropic Agents","id":"M0028009"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":null,"side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"United States","status":"Unscheduled","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Oxiracetam"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4626"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q415099"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB13601"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL36633"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A134788"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=62613-82-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0255986"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D07346"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9045180"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Oxiracetam"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/P7U817352G"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4626, Oxiracetam. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4626>https://pubchem.ncbi.nlm.nih.gov/compound/4626</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Oxiracetam. UNII: P7U817352G. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P7U817352G>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P7U817352G</a>","Oxiracetam for Injection, Package Insert. CSPC Pharmaceutical Group. <a href='https://www.e-cspc.com/upload/%E6%98%8E%E6%98%9F%E4%BA%A7%E5%93%81/files/%E6%B3%A8%E5%B0%84%E7%94%A8%E5%A5%A5%E6%8B%89%E8%A5%BF%E5%9D%A6.pdf'>https://www.e-cspc.com/upload/%E6%98%8E%E6%98%9F%E4%BA%A7%E5%93%81/files/%E6%B3%A8%E5%B0%84%E7%94%A8%E5%A5%A5%E6%8B%89%E8%A5%BF%E5%9D%A6.pdf</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 08:01:12","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 08:01:08","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 08:01:08","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 08:01:09","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 08:01:08","note":"hmdb.ca refused automated access to HMDB0255986"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 08:01:10","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 08:01:07","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 08:01:08","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 08:01:08","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 08:01:08","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 08:01:09","note":null}],"description":"Oxiracetam is a antipsychotic substance."}